CSI Market
Sign In | Register

Dmk Pharmaceuticals (DMK) Annual Balance Sheets

Annual · GAAP · USD millions
Access DMK quarterly Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Dmk Pharmaceuticals.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2022)
(Dec 31 2021) (Dec 31 2020) (Dec 31 2019) (Dec 31 2018)
Assets
Cash & cash equivalent1.08
Cash, Cash Equivalents Other0.03
Cash & Short-term Investments1.00
Accounts receivable1.05
Other Receivables0.03
Inventories1.24
Disposal Group, Including Discontinued Operation, Assets, Current AS3.95
Prepaid Expense And Other Assets Current1.88
Total Current Assets9.27
Equipment/Property/Plant Net1.29
Goodwill net0.00
Intangible Assets0.00
Financial Instruments0.00
Other Assets, Noncurrent0.37
Lease Right Of Use Asset0.00
Total Assets10.93
Liabilities
Accounts Payable, Current AC7.94
Accrued Liabilities, Current AC1.51
Financial Instruments0.00
Short-term Debt0.00
Other Liabilities, Current0.00
Deferred Revenue, Current DE0.03
Disposal Group, Including Discontinued Operation, Liabilities, Current LI1.27
Total Current Liabilities11.40
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.01
Deferred Revenue, Noncurrent DE0.18
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent0.00
Lease Liability Current0.31
Deferred Income Tax Liabilities Net-
Lease Liability Non Current-
Total Liabilities11.58
Stockholders' Equity
Common Stock Value0.02
Treasury Stock Value-0.01
Additional Paid In Capital Common Stock303.75
Retained Earnings / Accumulated Deficit-304.56
Other Equity-0.16
Common Stockholder's Equity-0.97
Non-controlling interests & other0.16
Total Stockholder's Equity-0.81
Liabilities & Stockholder's Equity10.93
4 historic quarters locked

Sign in to unlock the full Dmk Pharmaceuticals balance sheet history.

Sign In Create Free Account

About Dmk Pharmaceuticals Corp Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001999371-23-000197

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.